SCHEMBL15420943

SCHEMBL15420943

NC(=O)CC[C@H](N)C(=O)N[C@H](CS)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.53
BLM P54132 2/20 0.53
KMT2A Q03164 2/20 0.53
PMP22 Q01453 1/20 0.53
DPP4 P27487 2/20 0.51
DPP8 Q6V1X1 2/20 0.51
DPP9 Q86TI2 2/20 0.51
ACE P12821 1/20 0.50
PTGS1 P23219 2/20 0.48
GSTK1 Q9Y2Q3 1/20 0.48
FOLH1 Q04609 1/20 0.47
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS2 P35354 1/20 0.46
THPO P40225 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SLC7A11 Q9UPY5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5971076 1.00 ALOX15 (0.53) ALOX15BLMKMT2APMP22DPP4
SCHEMBL210007 1.00 ALOX15 (0.53) ALOX15BLMKMT2APMP22DPP4
SCHEMBL29420040 0.97 ALOX15 (0.50) ALOX15BLMKMT2APMP22DPP4
SCHEMBL30288042 0.95 ALOX15 (0.49) ALOX15BLMKMT2APMP22DPP4
SCHEMBL30288029 0.95 ALOX15 (0.49) ALOX15BLMKMT2APMP22DPP4
Glycine SCHEMBL2793248 0.94 ALOX15 (0.47) ALOX15BLMKMT2APMP22DPP4
SCHEMBL29924065 0.93 ALOX15 (0.46) ALOX15BLMKMT2APMP22DPP4
SCHEMBL4963576 0.93 ACE (0.55) ALOX15BLMKMT2APMP22DPP4
SCHEMBL6809858 0.92 KMT2A (0.49) ALOX15BLMKMT2APMP22DPP4
SCHEMBL6809847 0.92 KMT2A (0.49) ALOX15BLMKMT2APMP22DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9532961-B2 Method and kit for administering γ-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE (US) 2017-01-03 US disclosed
US-20160193167-A9 METHOD AND KIT FOR ADMINISTERING GAMMA-GLUTAMYL-D-CYSTEINE FOR THE PREVENTION OF REPERFUSION INJURY FOLLOWING ISCHEMIC STROKE ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE (US) 2016-07-07 US disclosed
US-20140024715-A1 METHOD AND KIT FOR ADMIINISTERING GAMMA-GLUTAMYL-D-CYSTEINE FOR THE PREVENTION OF REPERFUSION INJURY FOLLOWING ISCHEMIC STROKE ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE (US) 2014-01-23 US disclosed